AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2022

Feb 23, 2022

30893_dirs_2022-02-23_869343b2-779b-49b7-8343-f59920c41331.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2022-02-22

Reporting Person: Boehm Neil (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-22	Common Stock	S	5765.00	$30.3624	Disposed	30448.00	Direct
2022-02-22	Common Stock	A	10228.00	$0.00	Acquired	40676.00	Direct
2022-02-22	Common Stock	S	10228.00	$30.3624	Disposed	30448.00	Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price.

F3: 10,228 shares are performance based shares where the total number of shares granted were based on long term performance incentives as disclosed on Form 10K filed on February 23, 2022.